Brokerages Set Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) PT at $21.00
Artiva Biotherapeutics, Inc. (NASDAQ:ARTV – Get Free Report) has earned an average recommendation of “Buy” from the six ratings firms that are presently covering the company, MarketBeat Ratings reports. Six research analysts have rated the stock with a buy rating. The average 1-year target price among analysts that have issued ratings on the stock in […]
Artiva Biotherapeutics, Inc. (NASDAQ:ARTV – Get Free Report) has earned an average recommendation of “Buy” from the six ratings firms that are presently covering the company, MarketBeat Ratings reports. Six research analysts have rated the stock with a buy rating. The average 1-year target price among analysts that have issued ratings on the stock in […]
